Document Detail

Progression of coronary artery disease during long-term follow-up of the Swiss Interventional Study on Silent Ischemia Type II (SWISSI II).
MedLine Citation:
PMID:  20513067     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: This study evaluates cardiovascular risk factors associated with progression of coronary artery disease (CAD) in patients with silent ischemia following myocardial infarction. HYPOTHESIS: Coronary artery disease only progresses slowly with comprehensive risk factor intervention. METHODS: A total of 104 of 201 patients (51.7%) of the Swiss Interventional Study on Silent Ischemia Type II (SWISSI II) with baseline and follow-up coronary angiography were included. All patients received comprehensive cardiovascular risk factor intervention according to study protocol. Logistic regression was used to evaluate associations between baseline cardiovascular risk factors and CAD progression. RESULTS: The mean duration of follow-up was 10.3+/-2.4 years. At baseline, 77.9% of patients were smokers, 45.2% had hypertension, 73.1% had dyslipidemia, 7.7% had diabetes, and 48.1% had a family history of CAD. At last follow-up, only 27 patients of the initial 81 smokers still smoked, only 2.1% of the patients had uncontrolled hypertension, 10.6% of the patients had uncontrolled dyslipidemia, and 2.1% of the patients had uncontrolled diabetes. Coronary artery disease progression was found in up to 81 (77.9%) patients. Baseline diabetes and younger age were associated with increased odds of CAD progression. The time interval between baseline and follow-up angiography was also associated with CAD progression. CONCLUSION: Coronary artery disease progression was highly prevalent in these patients despite comprehensive risk factor intervention. Further research is needed to optimize treatment of known risk factors and to identify other unknown and potentially modifiable risk factors.
Andreas W Schoenenberger; Peiman Jamshidi; Richard Kobza; Michel Zuber; Andreas E Stuck; Matthias Pfisterer; Paul Erne
Related Documents :
18513637 - Sixty-four-slice computed tomography coronary angiography compared with myocardial perf...
9230147 - Identification of severe or extensive coronary artery disease in women by adenosine tec...
10420697 - Implications of an early reversal pattern of body surface potential maps in coronary ar...
19153177 - Prognostic utility of 64-slice computed tomography in patients with suspected but no do...
19851217 - Primary percutaneous coronary intervention: different outcome for different subgroups?
16603777 - Feasibility of transradial coronary angiography and angioplasty in chinese patients.
Publication Detail:
Type:  Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical cardiology     Volume:  33     ISSN:  1932-8737     ISO Abbreviation:  Clin Cardiol     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-05-31     Completed Date:  2010-09-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7903272     Medline TA:  Clin Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  289-95     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Wiley Periodicals, Inc.
Department of Geriatrics, Inselspital, Bern University Hospital, and Spital Netz Bern Ziegler, and University of Bern, Switzerland.
Data Bank Information
Bank Name/Acc. No.:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Transluminal, Percutaneous Coronary*
Antihypertensive Agents / therapeutic use
Antilipemic Agents / therapeutic use
Cardiovascular Agents / therapeutic use*
Chi-Square Distribution
Coronary Angiography
Coronary Stenosis / etiology*,  radiography,  therapy
Disease Progression
Hypoglycemic Agents / therapeutic use
Logistic Models
Middle Aged
Myocardial Infarction / etiology*,  radiography,  therapy
Myocardial Ischemia / etiology*,  radiography,  therapy
Odds Ratio
Risk Assessment
Risk Factors
Severity of Illness Index
Smoking Cessation
Time Factors
Reg. No./Substance:
0/Antihypertensive Agents; 0/Antilipemic Agents; 0/Cardiovascular Agents; 0/Hypoglycemic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The association of statin use and statin type and cognitive performance: analysis of the reasons for...
Next Document:  Effects of stem cell therapy on left ventricular remodeling after acute myocardial infarction: a met...